LYEL
#3137
Lyell Immunopharma, Inc. - Common Stock
14.9 6 USD
+0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+2.96%
Changement Mensuel
+16.24%
Evolution sur 6 mois
-36.61%
Changement Annuel
-38.16%
Clôture Précédente
14.5 3
Open
14.9 6
Low
14.9 6
High
14.9 6
Volume
19
Financials
- Market Capitalization 366.6 M
- Employee 161
- Founded 2018
- CEO N/A
- Website www.lyell.com
- Headquarter Delaware, United States
- FIGI BBG00RNXFN14
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.11
ratio cours/chiffre d'affaires
9 792.6
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3106 |  IPSC Century Therapeutics, Inc. - Common Stock | 2.11 USD | +3.94% | -1.86% | +4.46% | +348.94% | 382.07 M USD | ||
| 3130 |  IRD Opus Genetics, Inc. - Common Stock | 4.45 USD | +16.19% | +14.99% | +21.25% | +19.62% | 370.22 M USD | ||
| 3142 |  AGEN Agenus Inc. - Common Stock | 8.09 USD | +1.25% | -2.29% | +3.06% | +90.80% | 364.22 M USD | ||
| 3143 |  DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.75 USD | +4.65% | +1.05% | +2.27% | +27.60% | 364.00 M USD |